# MID America Apartment Communities Inc.: financial statements, quarterly

MAA · NYSE · CIK 912595 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/maa.md) · [Financials](/companies/maa/financials.md) · [Filings](/companies/maa/filings.md) · [Insiders](/companies/maa/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/maa/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [535](/filings/0000950170-24-089308.md) | [542](/filings/0000950170-24-119555.md) | [542 d](/filings/0001193125-26-041208.md) | [544](/filings/0000950170-25-061849.md) | [546](/filings/0000950170-25-100919.md) | [551](/filings/0001193125-25-258570.md) | [550 d](/filings/0001193125-26-041208.md) | [549](/filings/0001193125-26-197331.md) | [550](/filings/0000950170-25-100919.md) | [554](/filings/0001193125-25-258570.md) | [556 d](/filings/0001193125-26-041208.md) | [554](/filings/0001193125-26-197331.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [36.7](/filings/0000950170-24-089308.md) | [36.7](/filings/0000950170-24-119555.md) | [38.6 d](/filings/0001193125-26-041208.md) | [40.4](/filings/0000950170-25-061849.md) | [41.3](/filings/0000950170-25-100919.md) | [42.7](/filings/0001193125-25-258570.md) | [44.2 d](/filings/0001193125-26-041208.md) | [45.2](/filings/0001193125-26-197331.md) | [45.1](/filings/0000950170-25-100919.md) | [46.3](/filings/0001193125-25-258570.md) | [48.7 d](/filings/0001193125-26-041208.md) | [51.4](/filings/0001193125-26-197331.md) |
| Income tax | $m | [2.9](/filings/0000950170-24-089308.md) | [(0.2)](/filings/0000950170-24-119555.md) | [1.1 d](/filings/0001193125-26-041208.md) | [1.8](/filings/0000950170-25-061849.md) | [1.0](/filings/0000950170-25-100919.md) | [0.7](/filings/0001193125-25-258570.md) | [1.8 d](/filings/0001193125-26-041208.md) | [1.0](/filings/0001193125-26-197331.md) | [0.6](/filings/0000950170-25-100919.md) | [1.8](/filings/0001193125-25-258570.md) | [1.2 d](/filings/0001193125-26-041208.md) | [5.5](/filings/0001193125-26-197331.md) |
| Net income | $m | [146](/filings/0000950170-24-089308.md) | [111](/filings/0000950170-24-119555.md) | [160 d](/filings/0001193125-26-041208.md) | [144](/filings/0000950170-25-061849.md) | [102](/filings/0000950170-25-100919.md) | [115](/filings/0001193125-25-258570.md) | [167 d](/filings/0001193125-26-041208.md) | [182](/filings/0001193125-26-197331.md) | [108](/filings/0000950170-25-100919.md) | [99.5](/filings/0001193125-25-258570.md) | [57.6 d](/filings/0001193125-26-041208.md) | [124](/filings/0001193125-26-197331.md) |
| Diluted EPS | $ per share | [1.24](/filings/0000950170-24-089308.md) | [0.94](/filings/0000950170-24-119555.md) | not reported | [1.22](/filings/0000950170-25-061849.md) | [0.86](/filings/0000950170-25-100919.md) | [0.98](/filings/0001193125-25-258570.md) | not reported | [1.54](/filings/0001193125-26-197331.md) | [0.92](/filings/0000950170-25-100919.md) | [0.84](/filings/0001193125-25-258570.md) | not reported | [1.06](/filings/0001193125-26-197331.md) |
| Basic EPS | $ per share | [1.24](/filings/0000950170-24-089308.md) | [0.94](/filings/0000950170-24-119555.md) | not reported | [1.22](/filings/0000950170-25-061849.md) | [0.86](/filings/0000950170-25-100919.md) | [0.98](/filings/0001193125-25-258570.md) | not reported | [1.55](/filings/0001193125-26-197331.md) | [0.92](/filings/0000950170-25-100919.md) | [0.84](/filings/0001193125-25-258570.md) | not reported | [1.06](/filings/0001193125-26-197331.md) |

- Revenue: us-gaap:Revenues
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0000950170-24-089308.md) | [0.2](/filings/0000950170-24-119555.md) | [0.0](/filings/0001193125-26-041208.md) | [0.1](/filings/0000950170-25-061849.md) | [0.1](/filings/0000950170-25-100919.md) | [0.1](/filings/0001193125-25-258570.md) | [0.0](/filings/0001193125-26-041208.md) | [0.1](/filings/0001193125-26-197331.md) | [0.1](/filings/0000950170-25-100919.md) | [0.0](/filings/0001193125-25-258570.md) | [0.1](/filings/0001193125-26-197331.md) | [0.1](/filings/0001193125-26-197331.md) |
| Total assets | $bn | [11.4](/filings/0000950170-23-035158.md) | [11.4](/filings/0000950170-23-055620.md) | [11.5](/filings/0000950170-25-016287.md) | [11.5](/filings/0000950170-24-052131.md) | [11.6](/filings/0000950170-24-089308.md) | [11.8](/filings/0000950170-24-119555.md) | [11.8](/filings/0001193125-26-041208.md) | [11.8](/filings/0000950170-25-061849.md) | [11.8](/filings/0000950170-25-100919.md) | [11.9](/filings/0001193125-25-258570.md) | [12.0](/filings/0001193125-26-197331.md) | [12.0](/filings/0001193125-26-197331.md) |
| Total liabilities | $bn | [5.0](/filings/0000950170-23-035158.md) | [5.1](/filings/0000950170-23-055620.md) | [5.2](/filings/0000950170-25-016287.md) | [5.2](/filings/0000950170-24-052131.md) | [5.4](/filings/0000950170-24-089308.md) | [5.6](/filings/0000950170-24-119555.md) | [5.7](/filings/0001193125-26-041208.md) | [5.7](/filings/0000950170-25-061849.md) | [5.7](/filings/0000950170-25-100919.md) | [5.9](/filings/0001193125-25-258570.md) | [6.1](/filings/0001193125-26-197331.md) | [6.3](/filings/0001193125-26-197331.md) |
| Shareholders' equity | $bn | [6.2](/filings/0000950170-23-035158.md) | [6.1](/filings/0000950170-23-055620.md) | [6.1](/filings/0000950170-25-016287.md) | [6.1](/filings/0000950170-24-052131.md) | [6.0](/filings/0000950170-24-089308.md) | [5.9](/filings/0000950170-24-119555.md) | [5.9](/filings/0001193125-26-041208.md) | [5.9](/filings/0000950170-25-061849.md) | [5.9](/filings/0000950170-25-100919.md) | [5.8](/filings/0001193125-25-258570.md) | [5.7](/filings/0001193125-26-197331.md) | [5.5](/filings/0001193125-26-197331.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [336 d](/filings/0000950170-24-089308.md) | [318 d](/filings/0000950170-24-119555.md) | [265 d](/filings/0001193125-26-041208.md) | [200](/filings/0000950170-25-061849.md) | [349 d](/filings/0000950170-25-100919.md) | [310 d](/filings/0001193125-25-258570.md) | [239 d](/filings/0001193125-26-041208.md) | [197](/filings/0001193125-26-197331.md) | [353 d](/filings/0000950170-25-100919.md) | [266 d](/filings/0001193125-25-258570.md) | [262 d](/filings/0001193125-26-041208.md) | [150](/filings/0001193125-26-197331.md) |
| Dividends paid | $m | [163 d](/filings/0000950170-24-089308.md) | [163 d](/filings/0000950170-24-119555.md) | [163 d](/filings/0001193125-26-041208.md) | [172](/filings/0000950170-25-061849.md) | [172 d](/filings/0000950170-25-100919.md) | [172 d](/filings/0001193125-25-258570.md) | [172 d](/filings/0001193125-26-041208.md) | [177](/filings/0001193125-26-197331.md) | [177 d](/filings/0000950170-25-100919.md) | [177 d](/filings/0001193125-25-258570.md) | [177 d](/filings/0001193125-26-041208.md) | [179](/filings/0001193125-26-197331.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-26-197331.md) | not reported | not reported | not reported | [72.8](/filings/0001193125-26-197331.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [116](/filings/0000950170-23-035158.md) | [116](/filings/0000950170-23-055620.md) | [116](/filings/0000950170-24-052131.md) | [117](/filings/0000950170-24-089308.md) | [117](/filings/0000950170-24-119555.md) | [117](/filings/0000950170-25-061849.md) | [117](/filings/0000950170-25-100919.md) | [117](/filings/0001193125-25-258570.md) | [117](/filings/0001193125-26-197331.md) | [117](/filings/0000950170-25-100919.md) | [117](/filings/0001193125-25-258570.md) | [117](/filings/0001193125-26-197331.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 116,384,802 at 2026-04-27, from the cover of the [10-Q filed 2026-04-30](/filings/0001193125-26-197331.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 17:47 ET. No prices; not investment advice.